Akanda Corp. Raises $12M Via Convertible Note Offering
Ticker: AKAN · Form: 6-K · Filed: Sep 15, 2025 · CIK: 1888014
| Field | Detail |
|---|---|
| Company | Akanda Corp. (AKAN) |
| Form Type | 6-K |
| Filed Date | Sep 15, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $12.0 Million |
| Sentiment | neutral |
Sentiment: neutral
Topics: financing, convertible-note, offering
TL;DR
Akanda Corp. just announced a $12M convertible note offering. Bullish for cash flow.
AI Summary
Akanda Corp. announced a $12.0 million convertible note offering on September 12, 2025. The company, operating in the medicinal chemicals and botanical products sector, is based in New Romney, UK, and is filing this report under the 1934 Securities Exchange Act.
Why It Matters
This financing could provide Akanda Corp. with crucial capital to fund its operations or expansion, potentially impacting its stock price and future growth prospects.
Risk Assessment
Risk Level: medium — Convertible notes can dilute existing shareholders if converted, and the company's financial health and ability to repay the debt are key considerations.
Key Numbers
- $12.0M — Convertible Note Offering (Capital raised to fund operations or expansion.)
Key Players & Entities
- Akanda Corp. (company) — Registrant
- $12.0 million (dollar_amount) — Convertible Note Offering Amount
- September 12, 2025 (date) — Announcement Date
- Katie Field (person) — Interim Chief Executive Officer and Director
FAQ
What is the primary purpose of the $12.0 million convertible note offering?
The filing does not explicitly state the primary purpose, but such offerings are typically for general corporate purposes, including funding operations, expansion, or acquisitions.
When was the convertible note offering announced?
The convertible note offering was announced on September 12, 2025, as indicated by the press release filed as Exhibit 99.1.
Who signed the 6-K report on behalf of Akanda Corp.?
The report was signed by Katie Field, Interim Chief Executive Officer and Director.
What is Akanda Corp.'s Standard Industrial Classification?
Akanda Corp.'s Standard Industrial Classification is MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833].
What is the principal executive office address for Akanda Corp.?
The principal executive office is located at c/o Gowling WLG, 100 King St. W, Suite 1600, Toronto, ON M5X 1G5.
Filing Stats: 161 words · 1 min read · ~1 pages · Grade level 9.8 · Accepted 2025-09-12 18:32:43
Key Financial Figures
- $12.0 Million — Press Release – Akanda Announces $12.0 Million Convertible Note Offering 1 SIGNATUR
Filing Documents
- ea0257270-6k_akanda.htm (6-K) — 9KB
- ea025727001ex99-1_akanda.htm (EX-99.1) — 9KB
- 0001213900-25-087325.txt ( ) — 19KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AKANDA CORP. (Registrant) Date: September 12, 2025 By: /s/ Katie Field Name: Katie Field Title: Interim Chief Executive Officer and Director 2